Page 80 - Genomic Medicine in Emerging Economies

References 69

Profamilia, Ministerio de Salud y Protección Social, 2015. Encuesta Nacional de Demografía y
Salud Resumen Ejecutivo. 2015-1-96.
Pontificia Universidad Javeriana Bogotá. Especialización en Genética Médica. Available from:
http://www.javeriana.edu.co/especializacion-genetica-medica.
Rodríguez, A.O., Llacuachaqui, M., Pardo, G.G., Royer, R., Larson, G., Weitzel, J.N., et al., 2012.
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. Gynecol. On-
col. 124 (2), 236–243.
Rojas, W., Parra, M.V., Campo, O., Caro, M.A., Lopera, J.G., Arias, W., et al., 2010. Genetic make up
and structure of Colombian populations by means of uniparental and biparental DNA mark-
ers. Am. J. Phys. Anthropol. 143 (1), 13–20.
Ruiz-Linares, A., Adhikari, K., Acuña-Alonzo, V., Quinto-Sánchez, M., Jaramillo, C., Arias, W., et al.,
2014. Admixture in Latin America: geographic structure, phenotypic diversity and self-percep-
tion of ancestry based on 7,342 individuals. PLoS Genet. 10 (9), e1004572.
Scharf, J.M., Yu, D., Mathews, C.A., Neale, B.M., Stewart, S.E., Fagerness, J.A., et al., 2013. Genome-
wide association study of Tourette’s syndrome. Mol. Psychiatry 18 (6), 721–728.
SICREMI, OEA, 2014. Colombia—Síntesis histórica de la migración internacional en Colombia.
The World Bank, n.d. World Bank open data. Available from: https://data.worldbank.org/indica-
tor/SP.DYN.TFRT.IN?locations=CO&view=chart.
Torres, D., Rashid, M.U., Gil, F., Umana, A., Ramelli, G., Robledo, J.F., et al., 2007. High proportion
of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Breast Cancer Res. Treat. 103 (2), 225–232.
Torres D. UA, Robledo J. F., Caicedo, J.J., Quintero E., Orozco A., Torregrosa L., Tawil M., Hamann
U., Briceño, I., 2009. Estudio de factores genéticos para cáncer de mama en Colombia. Bogotá,
Colombia.
Tovar Pinzón, H., 2001. Emigración y éxodo en la historia de Colombia. Amérique Latine Histoire
et Mémoire. Les Cahiers ALHIM, pp. 1–11.
U.S Congress, Genetic Information Nondiscrimination Act of 2008. Available from: https://www.
congress.gov/bill/110th-congress/house-bill/00493.
Universidad del Rosario, 2017. Foro sobre financiación de la ciência tecnología e innovación en
Colombia. Available from: http://www.urosario.edu.co/Periodico-Nova-Et-Vetera/Actualidad-
Rosarista/En-Colombia-los-recursos-para-la-ciencia-vienen-ca/.
Vargas, I., Vázquez, M.L., Mogollón-Pérez, A.S., Unger, J-P., 2010. Barriers of access to care in a
managed competition model: lessons from Colombia. BMC Health Serv. Res. 10, 1–12.
Vargas, C.A., Carranza, H., Otero, J.M., Becerra, H.A., Acevedo, A., Rodríguez, J., et al., 2014. Per-
sonalized therapy for metastatic colorectal cancer in Colombia (ONCOLGroup). J. Clin. On-
col., 32.
Villarreal-Garza, C., Alvarez-Gómez, R.M., Pérez-Plasencia, C., Herrera, L.A., Herzog, J., Castillo,
D., et al., 2015. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mex-
ico. Cancer 121 (3), 372–378.
World Health Organization (WHO), 2010. Community Genetics Services: Report of a WHO Con-
sultation on Community Genetics in Low- and Middle-Income Countries. World Health Or-
ganization.
World Bank Group, 2014. Annual Report 2014. World Bank Group, pp 1–67.
The World Bank, 2016. Colombia. Available from: http://data.worldbank.org/country/colombia.